BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee YR, Kang MK, Song JE, Kim HJ, Kweon YO, Tak WY, Jang SY, Park JG, Lee C, Hwang JS, Jang BK, Suh JI, Chung WJ, Kim BS, Park SY. Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea. Clin Mol Hepatol. 2020;26:562-576. [PMID: 33053932 DOI: 10.3350/cmh.2020.0126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Russo FP, Piano S, Bruno R, Burra P, Puoti M, Masarone M, Montagnese S, Ponziani FR, Petta S, Aghemo A; Italian Association for the Study of the Liver. Italian association for the study of the liver position statement on SARS-CoV2 vaccination. Dig Liver Dis 2021;53:677-81. [PMID: 33941488 DOI: 10.1016/j.dld.2021.03.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Reference Citation Analysis]
3 Degarege A, Naveed Z, Kabayundo J, Brett-major D. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens 2022;11:563. [DOI: 10.3390/pathogens11050563] [Reference Citation Analysis]
4 Middleton P, Hsu C, Lythgoe MP. Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies. BMJ Open Gastroenterol 2021;8:e000739. [PMID: 34675033 DOI: 10.1136/bmjgast-2021-000739] [Reference Citation Analysis]
5 Leowattana W. Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients. World J Virol 2021; 10(3): 86-96 [PMID: 34079691 DOI: 10.5501/wjv.v10.i3.86] [Reference Citation Analysis]
6 Suri JS, Agarwal S, Gupta SK, Puvvula A, Biswas M, Saba L, Bit A, Tandel GS, Agarwal M, Patrick A, Faa G, Singh IM, Oberleitner R, Turk M, Chadha PS, Johri AM, Miguel Sanches J, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Ahluwalia P, Teji J, Al-Maini M, Dhanjil SK, Sockalingam M, Saxena A, Nicolaides A, Sharma A, Rathore V, Ajuluchukwu JNA, Fatemi M, Alizad A, Viswanathan V, Krishnan PK, Naidu S. A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence. Comput Biol Med 2021;130:104210. [PMID: 33550068 DOI: 10.1016/j.compbiomed.2021.104210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Lee YR. Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic. Korean J Gastroenterol 2021;77:156-9. [DOI: 10.4166/kjg.2021.402] [Reference Citation Analysis]
8 Su YJ, Chang CW, Chen MJ, Lai YC. Impact of COVID-19 on liver. World J Clin Cases 2021;9:7998-8007. [PMID: 34621856 DOI: 10.12998/wjcc.v9.i27.7998] [Reference Citation Analysis]
9 Su YJ, Chang CW, Chen MJ, Lai YC. Impact of COVID-19 on liver. World J Clin Cases 2021; 9(27): 7998-8007 [PMID: 34621856 DOI: 10.12998/wjcc.v9.i27.7998] [Reference Citation Analysis]
10 Jiang M, Mu J, Shen S, Zhang H. COVID-19 With Preexisting Hypercoagulability Digestive Disease. Front Med (Lausanne) 2020;7:587350. [PMID: 33521013 DOI: 10.3389/fmed.2020.587350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Song JE, Kang MK, Lee YR, Lee CH, Park JG, Kweon YO, Tak WY, Park SY, Jang SY, Hwang JS, Jang BK, Jang WY, Suh JI, Chung WJ, Kim BS; Daegu-Gyeongbuk Liver Study Group (DGLSG). Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment. Gut Liver 2021;15:606-15. [PMID: 33782216 DOI: 10.5009/gnl20267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Cho JY, Lee YS, Kim SS, Song DS, Lee JH, Kim JH. Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline. Clin Mol Hepatol 2021;27:515-23. [PMID: 34530524 DOI: 10.3350/cmh.2021.0293] [Reference Citation Analysis]
13 Jayant K, Reccia I, Virdis F, Pyda JS, Bachul PJ, di Sabato D, Barth RN, Fung J, Baker T, Witkowski P. COVID-19 in hospitalized liver transplant recipients: An early systematic review and meta-analysis. Clin Transplant 2021;35:e14246. [PMID: 33555058 DOI: 10.1111/ctr.14246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968 [PMID: 33969082 DOI: 10.12998/wjcc.v9.i13.2951] [Reference Citation Analysis]